Free Trial

443,305 Shares in agilon health, inc. (NYSE:AGL) Acquired by Quantbot Technologies LP

agilon health logo with Medical background

Quantbot Technologies LP purchased a new position in agilon health, inc. (NYSE:AGL - Free Report) during the 3rd quarter, according to its most recent disclosure with the SEC. The fund purchased 443,305 shares of the company's stock, valued at approximately $1,742,000. Quantbot Technologies LP owned 0.11% of agilon health as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of AGL. J.Safra Asset Management Corp lifted its position in shares of agilon health by 626.1% in the 2nd quarter. J.Safra Asset Management Corp now owns 4,204 shares of the company's stock worth $27,000 after acquiring an additional 3,625 shares during the period. CWM LLC increased its holdings in agilon health by 406.5% in the 2nd quarter. CWM LLC now owns 9,081 shares of the company's stock valued at $59,000 after buying an additional 7,288 shares during the period. Nisa Investment Advisors LLC acquired a new position in shares of agilon health in the 2nd quarter valued at $60,000. Allspring Global Investments Holdings LLC lifted its holdings in shares of agilon health by 17,790.0% during the 2nd quarter. Allspring Global Investments Holdings LLC now owns 10,734 shares of the company's stock worth $70,000 after acquiring an additional 10,674 shares during the period. Finally, Pallas Capital Advisors LLC bought a new position in shares of agilon health during the 2nd quarter worth about $77,000.

agilon health Price Performance

Shares of agilon health stock traded down $0.02 during midday trading on Friday, reaching $2.09. The company had a trading volume of 2,838,072 shares, compared to its average volume of 4,926,008. The stock has a fifty day simple moving average of $2.73 and a 200 day simple moving average of $4.63. agilon health, inc. has a 1-year low of $1.50 and a 1-year high of $13.76. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.06. The company has a market capitalization of $861.12 million, a price-to-earnings ratio of -2.22 and a beta of 0.60.

agilon health (NYSE:AGL - Get Free Report) last issued its quarterly earnings results on Thursday, November 7th. The company reported ($0.29) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.10) by ($0.19). agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. The firm had revenue of $1.45 billion for the quarter, compared to analyst estimates of $1.47 billion. During the same period last year, the company earned ($0.06) EPS. As a group, equities research analysts forecast that agilon health, inc. will post -0.47 earnings per share for the current year.

Analysts Set New Price Targets

AGL has been the subject of several recent research reports. JMP Securities lowered shares of agilon health from an "outperform" rating to a "market perform" rating in a research report on Monday, November 11th. Stifel Nicolaus dropped their target price on agilon health from $7.00 to $2.00 and set a "hold" rating for the company in a report on Tuesday, November 12th. Benchmark reaffirmed a "buy" rating and issued a $9.00 price target on shares of agilon health in a research note on Thursday, August 8th. William Blair lowered agilon health from an "outperform" rating to a "market perform" rating in a research note on Friday, November 8th. Finally, Royal Bank of Canada reissued an "outperform" rating and set a $3.00 price objective on shares of agilon health in a report on Tuesday, November 19th. Three analysts have rated the stock with a sell rating, fifteen have given a hold rating and two have issued a buy rating to the stock. According to MarketBeat, the company presently has an average rating of "Hold" and a consensus target price of $6.05.

Read Our Latest Research Report on AGL

Insider Buying and Selling

In related news, CEO Steven Sell bought 20,000 shares of agilon health stock in a transaction on Thursday, September 12th. The shares were purchased at an average price of $3.36 per share, for a total transaction of $67,200.00. Following the completion of the acquisition, the chief executive officer now owns 67,590 shares in the company, valued at approximately $227,102.40. This represents a 42.03 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. 3.20% of the stock is currently owned by insiders.

About agilon health

(Free Report)

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.

See Also

Institutional Ownership by Quarter for agilon health (NYSE:AGL)

→ Has Trump Finally Gone Too Far? (From Insiders Exposed) (Ad)

Should you invest $1,000 in agilon health right now?

Before you consider agilon health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and agilon health wasn't on the list.

While agilon health currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

From Landfills to Profits: Opal Fuels CEO Shares How the Company Turns Trash into Cash
The Real Reason Tesla Stock Is Soaring – and Why Tech Expert Says It Won’t Stop
Best ETFs for 2025: Growth, Stability, and AI-Driven Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines